Unicycive Therapeutics (UNCY) Earnings Date, Estimates & Call Transcripts $0.61 -0.04 (-6.52%) Closing price 05/6/2025 04:00 PM EasternExtended Trading$0.63 +0.02 (+3.72%) As of 05/6/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Unicycive Therapeutics Earnings Summary Upcoming Q1 Earnings DateMay. 12Before Market OpensEstimatedConsensus EPS (Mar. 27) -$0.13 Actual EPS (Mar. 27) -$0.26 Missed By -$0.13 Unicycive Therapeutics issued Q4 2024 earnings on March 27, 2025, reporting an EPS of -$0.26, which missed analysts' consensus estimates of -$0.13 by $0.13. With a trailing EPS of -$1.07, Unicycive Therapeutics' earnings are expected to grow next year, from ($0.23) to ($0.08) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportUNCY Upcoming EarningsUnicycive Therapeutics' next earnings date is estimated for Monday, May 12, 2025, based on past reporting schedules. Get Unicycive Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Unicycive Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataUNCY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.UNCY Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Unicycive Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.30-$0.08-$0.18Q2 20253-$0.31-$0.08-$0.17Q3 20253-$0.10$0.27$0.05Q4 20253-$0.10$0.36$0.13 Unicycive Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/12/2025(Estimated)--------3/27/2025Q4 2024-$0.13-$0.26 -$0.13-$0.26--8/14/2024Q2 2024-$0.23-$0.15+$0.08-$0.15--5/13/2024Q1 2024-$0.18-$0.27 -$0.09$0.07--3/28/2024Q4 2023-$0.18-$0.16+$0.02-$0.16--11/14/2023Q3 2023-$0.13-$0.13--$0.13--8/14/2023Q2 2023-$0.39-$0.29+$0.10-$0.29--5/16/2023Q1 2023-$0.36-$0.29+$0.07$0.39$0.75M$0.68M Unicycive Therapeutics Earnings - Frequently Asked Questions When is Unicycive Therapeutics's earnings date? Unicycive Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based off last year's report dates. Learn more on UNCY's earnings history. Did Unicycive Therapeutics beat their earnings estimates last quarter? In the previous quarter, Unicycive Therapeutics (NASDAQ:UNCY) missed the analysts' consensus estimate of ($0.13) by $0.13 with a reported earnings per share (EPS) of ($0.26). Learn more on analysts' earnings estimate vs. UNCY's actual earnings. How much revenue does Unicycive Therapeutics generate each year? Unicycive Therapeutics (NASDAQ:UNCY) has a recorded annual revenue of $680,000.00. How much profit does Unicycive Therapeutics generate each year? Unicycive Therapeutics (NASDAQ:UNCY) has a recorded net income of -$30.54 million. UNCY has generated -$1.07 earnings per share over the last four quarters. What is Unicycive Therapeutics's EPS forecast for next year? Unicycive Therapeutics's earnings are expected to grow from ($0.23) per share to ($0.08) per share in the next year. More Earnings Resources from MarketBeat Related Companies Monte Rosa Therapeutics Earnings Date ProKidney Earnings Date Atai Life Sciences Earnings Date Atyr PHARMA Earnings Date Phathom Pharmaceuticals Earnings Date Cryoport Earnings Date Astria Therapeutics Earnings Date Aquestive Therapeutics Earnings Date Aura Biosciences Earnings Date iTeos Therapeutics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Palantir Stock Drops Despite Stellar Earnings: What's Next?Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?Is Reddit Stock a Buy, Sell, or Hold After Earnings Release?Warning or Opportunity After Super Micro Computer's EarningsAmazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2 This page (NASDAQ:UNCY) was last updated on 5/7/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Unicycive Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Unicycive Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy UNCY Stock Free UNCY Stock Alerts